The Challenges of Reducing Biology to an Engineering Problem

A16Z has a vision of drug development becoming more and more like software development. The company is moving from a bespoke to an iterative process where platforms can take a modular approach to building medicine. What are some of the challenges you see in reducing biology to an engineering problem? I'm not this in the frame of just like we need combination therapies for certain diseases for HIV for cancer, we're going to need multiple technologies and methods to solve really complicated biology and human disease challenges," he says.